查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
失眠治療市場:按治療類型、按分銷渠道、按地區 - 規模、份額、前景、機會分析，2022-2028
市場調查報告書
商品編碼
1110117

失眠治療市場:按治療類型、按分銷渠道、按地區 - 規模、份額、前景、機會分析，2022-2028

Insomnia Treatment Market, By Treatment Type, By Distribution Channel, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

失眠症或失眠症是一種睡眠障礙，使您難以入睡。體徵和症狀包括入睡困難和睡眠不安。有時會使用安眠藥，但您應該注意它們的副作用。低劑量服用用於治療抑鬱症的處方藥可緩解失眠。失眠的認知行為療法（CBT-I）通常被推薦為一線治療。 CBT-I 是一個系統程序，可幫助您識別導致或加劇睡眠障礙的想法和行為，並用促進更好睡眠的習慣取而代之。

市場動態:

由於睡眠障礙的高發病率、對安全有效治療的需求不斷增加、公眾意識的提高以及全球人口老齡化的迅速增加，預計全球失眠治療市場將在預測期內增長。老年人失眠的患病率高於年輕人。與衰老、慢性疾病和環境條件相關的生理變化會導致老年人失眠。因此，隨著人口老齡化的增長，全球對安全有效的失眠治療的需求也在增加。例如，根據世界衛生組織（WHO）的數據，到 2030 年，全球六分之一的人口將超過 60 歲，到 2050 年，世界 60 歲以上的人口將翻一番，達到 21 億。

本研究的主要特點

  • 本報告對全球失眠治療市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR %)。
  • 解釋不同細分市場的潛在收入機會，並描述該市場具有吸引力的投資建議矩陣。
  • 它還提供有關市場驅動因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭策略等方面的重要見解。
  • 它根據以下參數描述了全球失眠治療市場的主要參與者，包括公司亮點、產品組合、關鍵亮點、財務業績和戰略。
  • 本研究涵蓋的主要公司包括:Innovative Neurological Devices、Cereve Inc.、Sanofi SA、輝瑞公司、Patek Pharmaceuticals Inc.、默克公司、武田製藥有限公司、Ebb Therapeutics 和 Electromedical產品國際公司等。
  • 本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 《全球失眠治療市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
  • 利益相關者可以通過用於分析全球失眠治療市場的各種戰略矩陣來促進他們的決策。

第一章研究目標和先決條件

  • 調查目的
  • 先決條件
  • 縮寫

第二章市場展望

  • 舉報內容
    • 市場定義和範圍
  • 執行摘要
    • 按治療類型劃分的鼻腔給藥模式市場
    • 鼻給藥方式市場:按分銷渠道
    • 鼻腔給藥模式市場:按地區劃分
  • 連貫的機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

  • 市場動態
    • 全球失眠症患病率不斷上升
    • 抗失眠藥物的典型副作用
    • COVID-19 爆發（持續大流行）
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/批准
  • PEST 分析
  • 對PORTER的分析
  • 併購方案

第 4 章失眠治療市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 的流行病學
  • 供應方和需求方分析
  • 經濟影響

第 5 章失眠治療市場，按治療類型，2017-2028 年

  • 藥物
  • 設備

第 6 章失眠治療市場:按分銷渠道，2017-2028

  • 醫院藥房
  • 零售藥房
  • 其他分銷渠道

第 7 章。失眠藥物市場:2017-2028 年各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地區

第 8 章競爭格局

  • Innovative Neurological Devices
  • Cereve Inc.
  • Sanofi SA
  • Pfizer Inc.
  • Paratek Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Takeda Pharmaceutical Company Ltd.
  • Ebb Therapeutics
  • Electromedical Products International Inc.

第九章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI958

Insomnia, or sleeplessness, is a sleep disorder in which people have trouble sleeping. Signs and symptoms may include difficulty falling or staying asleep and not feeling well-rested. Sleeping pills may also be used, but should be monitored for side effects. Sometimes prescription drugs used to treat depression may ease insomnia when taken in lower doses. Cognitive behavioral therapy for insomnia, CBT-I, is usually recommended as the first line of treatment. CBT-I is a structured program that helps people identify and replace thoughts and behaviors that cause or worsen sleep problems with habits that promote sound sleep.

Market Dynamics:

High prevalence of sleep disorders, growing demand for safe and effective treatment, increase in awareness among people, and rapidly growing geriatric population worldwide is expected to augment the growth of the global insomnia treatment market during the forecast period. The prevalence of insomnia is higher in elderly than in the younger population. Physiologic changes of aging, chronic medical illnesses, and environmental conditions contribute to insomnia in the elderly. Thus, with the growing geriatric population, the demand for safe & effective insomnia treatment worldwide. For instance, according to the World Health Organization (WHO), one in six people in the world will be aged 60 years or over by 2030, and the world's population of people aged 60 years and older will double (2.1 billion) by 2050.

Key features of the study:

  • This report provides in-depth analysis of the global insomnia treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global insomnia treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Innovative Neurological Devices, Cereve Inc., Sanofi SA, Pfizer Inc., Paratek Pharmaceuticals Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Ltd., Ebb Therapeutics, and Electromedical Products International Inc., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global insomnia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global insomnia treatment market.

Detailed Segmentation:

Global Insomnia therapeutics Market, By Treatment Type:

  • Drug
  • Device

Global Insomnia therapeutics Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

Global Insomnia therapeutics Market, By Geography:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Insomnia Treatment, By Treatment Type
    • Market Insomnia Treatment, By Distribution Channel
    • Market Insomnia Treatment, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in prevalence of insomnia across the globe
    • Characteristic side effects of insomnia drugs
    • Outbreak of COVID-19 (ongoing pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Insomnia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Insomnia Treatment Market, By Treatment Type, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Drug
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Device
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Insomnia Treatment Market, By Distribution Channel, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Distribution Channels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Insomnia Treatment Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Innovative Neurological Devices
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cereve Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Paratek Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co. Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Company Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ebb Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Electromedical Products International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us